The world’s newest petrostate heads to the polls
FT News Briefing
00:00
AstraZeneca's Corporate Struggles and Political Navigation in China
This chapter explores the repercussions of a scandal involving AstraZeneca's former China leader and its effects on the company's market performance in China. Despite a significant drop in share price due to legal issues, early signs of recovery and key interactions with Chinese officials underscore the complexities of operating within this political landscape.
Transcript
Play full episode
